Qualitative study on decision-making by prostate cancer physicians during active surveillance

被引:24
|
作者
Loeb, Stacy [1 ,2 ,3 ,4 ]
Curnyn, Caitlin [2 ]
Fagerlin, Angela [5 ,6 ]
Braithwaite, Ronald Scott [2 ]
Schwartz, Mark D. [2 ,4 ]
Lepor, Herbert [1 ,3 ]
Carter, Herbert Ballentine [7 ]
Sedlander, Erica [2 ]
机构
[1] NYU, Dept Urol, New York, NY USA
[2] NYU, Dept Populat Hlth, New York, NY USA
[3] NYU, Laura & Isaac Perlmutter Canc Ctr, New York, NY USA
[4] Manhattan Vet Affairs Med Ctr, New York, NY USA
[5] Univ Utah, Dept Populat Hlth Sci, Salt Lake City, UT USA
[6] Informat Decis Enhancement & Surveillance IDEAS C, Salt Lake City, UT USA
[7] Johns Hopkins Univ Hosp, Brady Urol Inst, Baltimore, MD 21287 USA
关键词
prostate cancer; active surveillance; markers; qualitative; survey; MANAGEMENT; MEN; GUIDELINE;
D O I
10.1111/bju.13651
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Objective To explore and identify factors that influence physicians' decisions while monitoring patients with prostate cancer on active surveillance (AS). Subjects and Methods A purposive sampling strategy was used to identify physicians treating prostate cancer from diverse clinical backgrounds and geographic areas across the USA. We conducted 24 in-depth interviews from July to December 2015, until thematic saturation was reached. The Applied Thematic Analysis framework was used to guide data collection and analysis. Interview transcripts were reviewed and coded independently by two researchers. Matrix analysis and NVIVO software were used for organization and further analysis. Results Eight key themes emerged to explain variation in AS monitoring: (i) physician comfort with AS; (ii) protocol selection; (iii) beliefs about the utility and quality of testing; (iv) years of experience and exposure to AS during training; (v) concerns about inflicting 'harm'; (vi) patient characteristics; (vii) patient preferences; and (viii) financial incentives. Conclusion These qualitative data reveal which factors influence physicians who manage patients on AS. There is tension between providing standardized care while also considering individual patients' needs and health status. Additional education on AS is needed during urology training and continuing medical education. Future research is needed to empirically understand whether any specific protocol is superior to tailored, individualized care.
引用
下载
收藏
页码:32 / 39
页数:8
相关论文
共 50 条
  • [1] 'It Just Makes Sense to Me': A qualitative study exploring patient decision-making and experiences with prostate MRI during active surveillance for prostate cancer
    Sutherland, Ryan
    Gross, Cary P.
    Ma, Xiaomei
    Jeong, Farah
    Seibert, Tyler M.
    Cooperberg, Matthew R.
    Catalona, William J.
    Ellis, Shellie D.
    Loeb, Stacy
    Schulman-Green, Dena
    Leapman, Michael S.
    BJUI COMPASS, 2024, 5 (06): : 593 - 601
  • [2] Prostate-specific antigen kinetics in clinical decision-making during active surveillance for early prostate cancer -: A review
    van den Bergh, Roderick C. N.
    Roemeling, Stijn
    Roobol, Monique J.
    Wolters, Tineke
    Schroder, Fritz H.
    Bangma, Chris H.
    EUROPEAN UROLOGY, 2008, 54 (03) : 505 - 516
  • [3] Patient participation in treatment decision-making of prostate cancer: a qualitative study
    Shucheng Pan
    Jinjiao Mao
    Lijuan Wang
    Yun Dai
    Wei Wang
    Supportive Care in Cancer, 2022, 30 : 4189 - 4200
  • [4] Patient participation in treatment decision-making of prostate cancer: a qualitative study
    Pan, Shucheng
    Mao, Jinjiao
    Wang, Lijuan
    Dai, Yun
    Wang, Wei
    SUPPORTIVE CARE IN CANCER, 2022, 30 (05) : 4189 - 4200
  • [5] Informational needs during active surveillance for prostate cancer: A qualitative study
    Loeb, Stacy
    Curnyn, Caitlin
    Fagerlin, Angela
    Braithwaite, R. Scott
    Schwartz, Mark D.
    Lepor, Herbert
    Carter, H. Ballentine
    Ciprut, Shannon
    Sedlander, Erica
    PATIENT EDUCATION AND COUNSELING, 2018, 101 (02) : 241 - 247
  • [6] Selecting Active Surveillance: Decision-Making Factors for Men with a Low-Risk Prostate Cancer
    Hoffman, Richard M.
    Lobo, Tania
    Van Den Eeden, Stephen K.
    Davis, Kimberly M.
    Luta, George
    Leimpeter, Amethyst D.
    Aaronson, David
    Penson, David F.
    Taylor, Kathryn
    MEDICAL DECISION MAKING, 2019, 39 (08) : 962 - 974
  • [7] SELECTING ACTIVE SURVEILLANCE: DECISION-MAKING FACTORS FOR MEN WITH A LOW-RISK PROSTATE CANCER
    Hoffman, Richard M.
    Lobo, Tania
    Van den Eeden, Stephen K.
    Luta, George
    Davis, Kimberly M.
    Aaronsen, David
    Taylor, Kathryn L.
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2018, 33 : S336 - S336
  • [8] Making Active Surveillance a path towards health promotion: A qualitative study on prostate cancer patients' perceptions of health promotion during Active Surveillance
    Menichetti, Julia
    De Luca, Letizia
    Dordoni, Paola
    Donegani, Simona
    Marenghi, Cristina
    Valdagni, Riccardo
    Bellardita, Lara
    EUROPEAN JOURNAL OF CANCER CARE, 2019, 28 (03)
  • [9] A qualitative study of factors in nurses' and physicians' decision-making related to family presence during resuscitation
    Twibell, Renee
    Siela, Debra
    Riwitis, Cheryl
    Neal, Alexis
    Waters, Nicole
    JOURNAL OF CLINICAL NURSING, 2018, 27 (1-2) : E320 - E334
  • [10] Australian men with low risk prostate cancer and their partners' experience of treatment decision-making and active surveillance
    Hyatt, Amelia
    O' Callaghan, Clare
    Dryden, Tracey
    Burney, Sue
    Wootten, Addie
    Brooker, Joanne
    Fletcher, Jane
    Frydenberg, Mark
    Murphy, Declan
    White, Alan
    Schofiled, Penelope
    BJU INTERNATIONAL, 2013, 112 : 64 - 64